In-Vitro Selection of Ceftazidime/Avibactam Resistance in OXA-48-Like-Expressing Klebsiella pneumoniae: In-Vitro and In-Vivo Fitness, Genetic Basis and Activities of β-Lactam Plus Novel β-Lactamase Inhibitor or β-Lactam Enhancer Combinations

Ceftazidime/avibactam uniquely demonstrates activity against both KPC and OXA-48-like carbapenemase-expressing Enterobacterales. Clinical resistance to ceftazidime/avibactam in KPC-producers was foreseen in in-vitro resistance studies. Herein, we assessed the resistance selection propensity of cefta...

Descripción completa

Detalles Bibliográficos
Autores principales: Palwe, Snehal, Bakthavatchalam, Yamuna Devi, Khobragadea, Kshama, Kharat, Arun S., Walia, Kamini, Veeraraghavan, Balaji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8614831/
https://www.ncbi.nlm.nih.gov/pubmed/34827256
http://dx.doi.org/10.3390/antibiotics10111318

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8614831/
https://www.ncbi.nlm.nih.gov/pubmed/34827256
http://dx.doi.org/10.3390/antibiotics10111318

Ejemplares similares